Operation Warp Speed
ie:
How to Catch a Predator.
Everyone, who is/was involved in the plot, to KILL OFF over HALF the Population, will be exposed.
MK
Mind Kontrol
Numerous Projects, Name Hopping (Sound familiar? Pickles)
This seems to be the lead in, to the Chemtrails that everyone Railed against, in their slumber of Cognitive Dissonance, and Defense of "Con" trails, not realizing that THEY were the ones, being Conned.
National Security Archive Publishes Key Records on Infamous MKULTRA Program
Agency Sought Drugs and Behavior Control Techniques to Use in “Special Interrogations” and Offensive Operations
Sidney Gottlieb’s CIA Personnel File, 1983 Deposition Testimony, Among Newly Available Documents
https://nsarchive.gwu.edu/briefing-book/dnsa-intelligence/2024-12-23/cia-behavior-control-experiments-focus-new-scholarly
[THEY] have reduced humanity to a meme.
It's not the "CAR", it's the CHOICE to turn your power over to something else.
In EVERY aspect.
Trump Is Taking Remdesivir. Here's How It Works To Control The Coronavirus
OCT. 3, 2020
President Trump is on day two of a planned 5-day course of remdesivir. The medication, approved for treating COVID-19, works by making it harder for the coronavirus to replicate within the body
https://www.ncbi.nlm.nih.gov/search/research-news/11569/#:~:text=Here's%20How%20It%20Works%20To%20Control%20The%20Coronavirus&text=President%20Trump%20is%20on%20day,to%20replicate%20within%20the%20body.
Are Trumps medical issues, directly related to a side effect of Remdesivere?
The FAKE NEWS really highlights his Bruises, swollen ankles, and the latest "he died" posts.
What do they know?
What are the pushing?
Would THIS NEWS Wake the WORLD???
>Remdesiver or Regeneron?
Article said Remdisiver
>you are full of shit
You are a Mental Midget.
That was a DIRECT REPORT FROM NIH.
Filtered for being low vibe
Remarks by President Trump in Announcement on Remdesivir
HEALTHCARE
3:37 P.M. EDT
THE PRESIDENT: Well, thank you very much. And welcome to Dan O’Day, CEO of Gilead. You know what that is because it’s been in the news and the company has been in the news, and it’s a great American company that’s done incredible work on HIV and hepatitis C. And I hear that — that’s what’s happening with hepatitis is the great — a great medical story. Really, a great medical story. I’ve been hearing about that. It’s fantastic, Dan.
I’m pleased to announce that Gilead now has an EUA from the FDA for remdesivir. And you know what that is because that’s been the hot thing also in the papers and in the media for the last little while. An important treatment for hospitalized coronavirus patients. And it’s something — I spoke with Dr. Hahn and Dr. Fauci; I spoke with Deborah about it. And it’s — it’s really a very promising situation.
We’ve been doing work with the teams at the FDA, NIH, and Gilead for spearheading this public-private partnership to make this happen very quickly.
So, today, we’re going to be — and I’m going to let Dan do it — but we’re going to let Dan make a statement as to what the company is doing, making a contribution to, really, people that are not doing well, people that are sick, people that have this horrible plague that’s set into our country and that we’re getting rid of. And we’re going to be — we’re going to be having some really incredible results.
We have very promising studies coming out on the vaccines. We have promising studies coming out on therapeutics. And the first one is from Dan and Gilead. And I’d like to maybe have you say a few words, if you would, Dan, as to, number one, about remdesivir, to start off with, and also the contribution being made by your company. And we very much appreciate it.
MR. O’DAY: Sure. Thank you very much, Mr. President. Thank you for having us here. Thank you, Mr. Vice President, for the collaboration that we’ve had.
Let me start by saying, on behalf of, I know, all the colleagues at Gilead, we want to thank all the collaborators that have brought remdesivir to this point. And that certainly includes NIH and Dr. Fauci and certainly Commissioner Hahn, and many, many more people that have been a part of this to bring this to where we are today.
And, in fact, really, the thanks go to the patients and the caregivers that participated in these clinical trials.
I also want to say I’m privileged to work with a group of amazing scientists at Gilead that, for decades, have been working on antivirals and were poised to put remdesivir immediately into clinical trials when we saw the COVID-19 circulating. So I’m really proud of the colleagues back at Gilead.
What I’d like to say is that, you know, on behalf of Gilead, to the President’s point, we feel a tremendous responsibility. We’re humbled by this being an important first step for patients, for hospitalized patients. We want to make sure nothing gets in the way of these patients getting the medicine. So we made a decision to donate about 1.5 million vials of remdesivir.
We’ll be working with the government to determine how best to distribute that within the United States. We’ll be working very closely to get that to patients, working with FEMA, working with other parts of the government to make sure that we get that to the patients in need as quickly as possible, because there are patients out there that can benefit from this medicine today that are hospitalized, and we don’t want any time to waste for that.
Issued on: May 1, 2020
Moar
https://trumpwhitehouse.archives.gov/briefings-statements/remarks-president-trump-announcement-remdesivir/